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Abstract Studies on the prevalence and impact of psy-
chiatric disorders among headache patients have yielded
findings that have clarified the relationship between
migraine and major affective disorders, anxiety, illicit drug
abuse, nicotine dependence, and suicide attempts. Studies in
both clinical and community-based settings have demon-
strated an association between migraine and a number of
specific psychiatric disorders. In large-scale population-
based studies, persons with migraine are from 2.2 to 4.0
times more likely to have depression. In longitudinal
studies, the evidence supports a bidirectional relationship
between migraine and depression, with each disorder
increasing the risk of the other disorder. Although a strong
association has been demonstrated consistently for migraine
and major depression, especially for migraine with aura,
there has been less systematic research on the links between
migraine and bipolar disorder. This review will focus on the
way in which psychiatric disorders decrease the quality of
life and result in a worse prognosis, chronicity of the dis-
ease, and a worse response to treatment. Short-term phar-
maceutical care intervention improves the patients’ mental
health, but it does not significantly change the number and
severity of headaches. The increase in self-efficacy and
mental health associated with pharmaceutical care may be
instrumental in improving the long-term pharmacotherapy
of patients with migraine and headache.
Keywords Psychiatric disorders  Headache 
Suicide risk  Treatment
Introduction
Chronic daily headache (CDH) refers to a group of disor-
ders in which headache occurs 15 or more days per month
for at least 3 months [1–5] and includes: chronic migraine
(CM), migraine with or without aura and migraine aura
without headache, chronic tension-type headache (CTTH),
hemicrania continua (HC), and new daily persistent head-
ache [6–8].
Chronic migraine (CM) affects 2.4% of the general
population [5] and it is often comorbid with other condi-
tions, such as depression (80%) [9], anxiety (70%) [9, 10],
insomnia (71%) [11], chronic fatigue (66%) [12], and
fibromyalgia (35%) [13]. Recently, studies have viewed the
relationship between migraine and psychiatric disorder as
(1) bi-directional [14] since migraine patients have a more
than threefold risk of developing depression and (2) spe-
cific [15] since the presence of migraine increases a
patient’s risk of developing depression or panic attack
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disorder and the presence of depression or panic attack
disorder is associated with a greater risk of developing
migraine.
Sheftel and Atlas [16], looking at clinical manifestations
associated with daily chronic headache, found a high inci-
dence of anhedonia, decreased concentration, decreased
libido, decreased energy, and sleep disorders, all character-
istic elements of depression. They proposed that headache
is not simply a symptom of depression, but that headache
and several mood and anxiety disorders are clinical entities
that share some pathophysiological bases [15, 17–24],
most likely disturbances in the serotonergic systems [20,
25–27].
Epidemiology
Epidemiological research has indicated an association
between migraine and mood disorder with a lifetime preva-
lence of major depression three times higher among patients
with migraine when compared with patients without
migraine [28]. This comorbidity between CDH and psychi-
atric disorders seems to be more frequent in women, in
chronic forms of migraine [29] and in first-degree relatives of
patients with mood disorder and migraine [21]. Migraine
with aura is strongly associated with an early age of onset of
the mood disorder (OR 11.4, age \ 15 years; OR 5.6, age
15–24 years) [20]. Migraine, weekly or daily, occurs in
3–15% of children [30, 31] while 9–33% of individuals
suffer from non-migraine headache at least monthly [31].
The prevalence of migraine is highest among patients with
bipolar II disorder (77%), and this is significantly different
from the prevalence among bipolar I patients (14%) [32].
The unipolar group has a prevalence of 46%, in between the
two bipolar groups [32]. This is in broad agreement with the
study by Endicott [33], who found a 51% prevalence of
migraine in patients with characteristics similar to bipolar II
patients. The results of some epidemiological studies are
shown in Table 1.
Psychiatric disorders and headache
The presence of migraine or severe non-migraine headache
increases a patient’s risk of developing depression or panic
attack disorder, whereas the presence of depression or
panic attack disorder is associated with a greater risk of
developing migraine, but not severe non-migraine head-
ache [15]. Merikangas and colleagues [17], in a prospective
study, supported the idea that anxiety induces or facilitates
the onset of a primary headache, acting as trigger for
the subsequent development of a mood disorder such as
depression. People suffering from migraine were 12 times
more likely to suffer from panic attacks [21] and 2.5 times
more likely to suffer from depression.
Psychiatric comorbidity is more frequent in chronic pain
syndromes, such as the chronic form of migraine [34]. It is
important to distinguish between migraine with or without
aura and aura without headache. In one population-based
epidemiological study [17, 35], migraine with aura was
associated with anxiety disorders, recurrent brief depression
and hypomania, whereas only the phobic and panic disorders
were more frequent among patients suffering from migraine
without aura. Patients with tension-type headache did not
differ from controls with respect to any of the affective or
anxiety disorders. Oedegaard and colleagues [20] showed
that a large number of patients presenting with major
affective disorders have migraine aura without headache.
These patients had a lower frequency of an affective tem-
perament and a lower probability of having made a suicide
attempt, as well as a higher age of onset of migraine auras
relative to patients suffering from migraine with aura.
The more common psychiatric conditions related to
migraine are depression, bipolar disorders, anxiety [(especially,
Table 1 Prevalence of
migraine in bipolar disorder
from previous studies
DIGS Diagnostic Interview for
Genetic Studies, IHS
International Headache Society
Source Method Sample size Migraine
prevalence (%)




Cassidy and Flanagan (1957) Self-report of headache N = 100 Total 49.0




Marchesi et al. (1989) Diagnosis by neurologist N = 30 Total 20.0
Fasmer (2001) Administered IHS migraine criteria N = 27 Bipolar I 13.0
Bipolar II 77.0
Younes et al. (1986) Mother’s report of past diagnosis
of migraine
N = 21 Total 28.6
Females = 0
Male = 21
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generalized anxiety disorders (GAD)] [17, 36] and somato-
form disorders. These comorbid disorders have been identi-
fied in several epidemiological studies [22, 37–40] as well as
in clinical studies of treatment-seeking patients [34, 40, 41].
The association between migraine and depression has also
been studied in a number of large-scale community studies
(Table 2).
The association of CDH with psychiatric disorders is con-
troversial, especially with regard to depression (Table 3).
Verri and colleagues [10] found an association between CDH
and at least one psychiatric disorder in 90% of their patients,
mainly GAD, followed by major depression (25%) and dys-
thymia (17%). Verri [10] and later Juang [48] confirmed that a
longer major depressive disorder (or chronic depression) was
the most frequent comorbidity among these patients, espe-
cially when the chronic headache had lasted for more than
5 years. However, Juang and colleagues [48] found that the
frequency of any type of anxiety disorder was significantly
higher in patients with chronic migraine than in those with
CTTH. In prior research, the comorbidity between tension-
type headache and psychiatric disorders has been investigated
only in clinical populations, in which it has been showed that
this association is more common in the chronic form of ten-
sion-type headache [14]. In fact, the frequency of anxiety and
mood disorders were 3–15 times higher in CTTH patients than
in controls [14], and the frequencies reported were 21% for
depression and 17% for anxiety disorders in these patients
[41], with significantly higher anxiety and depression scores
[41, 49]. Moreover, in previous studies, especially in the
chronic form of tension-type headache, affective disorders
were found to be frequent [50, 51]. Of the three studies
conducted in clinical samples, none reported any significant
differences in psychiatric comorbidity between migraine and
tension-type headache [49, 52, 53].
There has been less research on the role of personality
disorders in headache. Mathew [54] found significantly
higher abnormal personality profiles in CDH patients than
in controls using the Minnesota Multiphasic Personality
Inventory (MMPI) but found no difference in the profiles of
patients with different subtypes of CDH. In a small sample

























Merikangas [43] Diagnosis by neurologist 2.2 (1.1–4.8) Not assessed




Swartz [44] IHS migraine criteria 3.1 (2.0–4.4) New-onset migraine
0.68 (0.02–2.0)
Zwart [45] IHS migraine criteria 2.7 (2.3–3.2) Not assessed
McWilliams [46] Diagnosis by neurologist 2.8 (2.2–3.7) Not assessed
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study, high MMPI scores have been reported for the
hypochondriasis and hysteria scales in CDH patients [55].
Galli and colleagues noted that only 9.6% of patients did
not have familial occurrence of headache, with a half of the
sample (49%) showing both parents and grandparents com-
plaining of headache. Galli et al. [56] stressed the importance
of familial recurrence (mainly for the mother) for migraine
and psychiatric disorders, but less so for tension-type head-
aches and psychiatric disorders. The tension-type headache
group had higher temperament traits of emotionality and
shyness, and lower sociability, than the migraine group [57].
A higher emotionality score was also found among the par-
ents and siblings of tension-type headache children [57].
Thus, high scores for emotionality and shyness can be con-
sidered to be symptoms of ‘behavioral inhibition’ [58, 59],
characterized by the traits of irritability, shyness, fearfulness,
and introversion. In school-age children, the presence of this
temperament seems to increase the vulnerability to depres-
sive and multiple anxiety disorders [60, 61]. Tension-type
headache patients may have, as a group, more behavioral,
emotional, and temperament difficulties than children
referred for migraine [56]. This finding seems to be in con-
trast with an epidemiological study in Finland, which found
that psychiatric symptoms tended to be more strongly asso-
ciated with migraine than with tension-type headache [62].
However, personality disorders are considered to be a com-
plication for headache management [63–65], and significant
headaches are a complaint of about 60% of patients with
personality disorders presenting for acute treatment at a
hospital emergency department [65].
Suicide risk
Suicide attempts seem to be more frequent in patients
suffering from migraine than in the general population,
especially in females and in patients with migraine with
aura. This association has also been found in the general
population [22, 35, 43, 66]. In contrast, the subtypes of
CDH, headache frequencies, or medication overuse were
not correlated with the risk of attempted suicide [66].
Migraine with aura also independently predicted a high
suicidal risk (score[ 10 on the MINI Suicidality Module) in
adolescents with CDH [66], despite the fact that it is very
difficult to predict suicide in youths. A history of migraine
with aura, but not migraine without aura, has been found to be
associated with an increased frequency of suicidal ideation
and suicide attempts in patients with major depression in
several studies [22, 39, 66], both current and previous affec-
tive episodes [20, 28]. Oedegaard and colleagues found that
only 17% of patients having migraine aura without headache
had made a suicide attempt, and these patients has the lowest
frequency of affective temperaments as well as a higher age of
onset of migraine auras [28]. However, the frequencies of
suicidal ideation were approximately equal in the two groups
of migraine patients [28].
Table 3 Studies of psychiatric comorbidity in patients with chronic daily headache




Mood disorders (%) Anxiety
disorders (%)
Mathew et al. [54] By their own criteria MMPI subscore 61 Not assessed




Puca et al. [34] IHS CIDI-by physicians 45 56
Mitsikostas and
Thomas [49]
IHS ? mixed type
headache
Psychiatric evaluation
if HDRS [ 16
10 (10 in CTTH, 19 in
MOH, 9 in mixed type)
Not assessed
Wang et al. [76] Adopted criteria of
Silberstein et al.
[2] ? IHS for CTTH
DSM IV (GDS-S) 29 Not assessed
Juang et al. [48] Adopted criteria of
Silberstein et al. [2]





Holroyd et al. [41] IHS BDI Major depressive
disorder: 21
17
Atasoy et al. [75] ICHD II DSM IV (SCID-II,
SCID-CV)
37.3 (25 in Group C; 51.6
in Group E; 36.2 in
Group M)
15.3 (10.7 in Group C;
16.1 in Group E; 17.2
in Group M)
MINI International Neuropsychiatric Interview; SCID the Structured Clinical Interview for DSM-IV; GDS-S Geriatric Depression Scale-short
Form; IHS International Headache Society; CTTH Chronic Tension-type Headache; MMPI Minnesota Multiphasic Personality Inventory; HDRS
Hamilton Depression Rating Scale; GAD Generalized Anxiety Disorder; BDI Beck Depression Inventory; CIDI Composite International
Diagnostic Interview; ICHD-II The international classification of headache disorders, 2nd edition; MOH Medication-Overuse Headache
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Breslau [39] found an association of migraine with aura
with suicide attempts that was not necessarily due to coex-
isting major depression. Migraine with aura alone was
associated with significantly higher rates of suicidal ten-
dencies. The risk of suicidal inclinations associated with
migraine with aura and major depressive disorder was much
higher than that for those with only major depressive disorder
[67]. CDH is a source of great distress, with impairment of
pleasure and working activities. This decreased of quality of
life can result in hopelessness and despair, and suicidal
wishes can easily emerge [67]. However, the pain of head-
aches is itself is a potential independent risk factor for sui-
cide, particularly among those with chronic headache or
multiple sources of co-occurring pain [68]. Individuals
suffering from chronic pain may be particularly appropriate
for suicide screening and intervention efforts. Innamorati and
colleagues [69] have proposed a new scale, the Italian
Perceived Disability Scale, as screening tool to identify
comorbidity with emotional distress and disorders. This scale
has proved able to predict suicidal intent in CDH patients and
to assess disability in a sample of patients with CDH [69].
Treatment
The use of psychoactive drugs can influence the frequency
and modify the clinical features of migraine headaches. For
acute treatment, sumatriptan, nonsteroidal anti-inflamma-
tory agents, ergotamine, and dihydroergotamine have been
used, and metoclopramide is often co-administered.
The SSRIs (paroxetine and fluvoxamine) remain the first-
choice medications for mood disorders related to migraine,
although long-term treatment with serotonergic compounds
does not impact the migraine itself. The SSRIs can also be
used for the long-term treatment of panic disorder without
mood disorders, tension-type headache, obsessive-compul-
sive disorder and somatoform disorder [70]. Regarding GAD
and tension-type headache, the administration of BZDs is
possible, but long-term therapy with BZD is not feasible
because of the development of tolerance. In GAD long term
therapy, SSRI (paroxetine) could represent a valid alternative
to BZD if starting with a minimal effective dosage. The aim is
to customize treatment as much as possible. The association
between migraine and panic disorder and bipolar disorder or
unipolar disorder can be treated with VPA, which is effective
in the control of panic [71].
For the preventive treatment of mood disorders related
to migraine or tension-type headache, the recommended
therapy is to use antidepressive tricyclics (TCAs) [72],
such as amitriptyline, as monotherapy or a combination
of amitriptyline and an SSRI such as paroxetine [16] or
flunarizine [73] and mood stabilizers such as lithium [21] or
valproate [73, 74]. These have been tested and found to be
useful for migraine prophylaxis. No studies have reported a
positive effect of the SSRIs on the aura symptoms. The better
strategies are summarized in Tables 4 and 5.
Although, short-term pharmaceutical care intervention
improves patients’ mental health, it does not significantly change
the number and severity of headaches. However, the increase in
self-efficacy and mental health associated with pharmaceutical
care may be instrumental in improving the long-term pharma-
cotherapy of patients with migraine and headache.
Conclusion
Several studies have analyzed the prevalence and impact of
psychiatric disorders among headache patients, and these
Table 4 Preventive treatments in headache associated with depres-
sive syndrome
Preventive treatment
Migraine ? depression ? anxious symptoms:




Migraine ? depression with psychomotor slowing:










Migraine ? panic disorder: VPA
Migraine ? panic disorder ? bipolar disorder: VPA





Migraine ? depression ? secondary panic disorder
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studies have resulted in a better understanding of the
relationship between migraine and mood disorders,
anxiety, and suicide attempts. Unfortunately, as noted by
Silberstein et al. [2], the relationship between headache and
psychopathology has often been discussed only clinically
rather than systematically studied. Furthermore, the
investigation of the interplay of factors that precipitate
suicide risk should include the assessment of chronic
headache and its effects on well-being. These issues, as
well as those discussed in this paper, represent an important
area for future research.
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